Market Research Logo

Avita Medical Ltd (AVH) - Product Pipeline Analysis, 2018 Update

Summary

Avita Medical Ltd (Avita Medical) is a medical device company that develops and distributes regenerative, tissue-engineered products for treating burns, scars, wounds, and skin defects. The company’s medical device portfolio includes ReCell for the treatment of burns and plastic reconstructive procedures; ReGenerCell for chronic wounds including leg and foot ulcers; and ReNovaCell for aesthetic applications including the restoration of pigmentation. Avita Medical distributes its products through its direct sales force in Australia and through distributors in the UK, France, Germany, Austria, Switzerland, Turkey, China, Japan, Taiwan, Saudi Arabia, South Korea and the US. Avita Medical is headquartered in London, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Avita Medical Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


  • Avita Medical Ltd Company Overview
    • Avita Medical Ltd Company Snapshot
    • Avita Medical Ltd Pipeline Products and Ongoing Clinical Trials Overview
      • Table Avita Medical Ltd Pipeline Products and Ongoing Clinical Trials Overview
      • Table Avita Medical Ltd Pipeline Products by Equipment Type
      • Table Figure 1: Avita Medical Ltd Pipeline Products by Equipment Type
      • Table Avita Medical Ltd Pipeline Products by Indication
  • Avita Medical Ltd – Pipeline Analysis Overview
    • Business Description
    • Avita Medical Ltd - Key Facts
      • Table Avita Medical Ltd, Key Facts
    • Avita Medical Ltd - Major Products and Services
      • Table Avita Medical Ltd, Major Products and Services
    • Avita Medical Ltd Pipeline Products by Development Stage
      • Table Figure 2: Avita Medical Ltd Pipeline Products by Development Stage
      • Table Avita Medical Ltd Number of Pipeline Products by Development Stage
      • Table Avita Medical Ltd Pipeline Products Summary by Development Stage
    • Avita Medical Ltd Ongoing Clinical Trials by Trial Status
      • Table Figure 3: Avita Medical Ltd Ongoing Clinical Trials by Trial Status
      • Table Avita Medical Ltd Ongoing Clinical Trials by Trial Status
      • Table Avita Medical Ltd Ongoing Clinical Trials Summary
  • Avita Medical Ltd Pipeline Products Overview
    • ReGenerCell - Diabetic Foot Ulcers
      • ReGenerCell - Diabetic Foot Ulcers Product Overview
        • Table ReGenerCell - Diabetic Foot Ulcers - Product Status
        • Table ReGenerCell - Diabetic Foot Ulcers - Product Description
      • ReGenerCell - Diabetic Foot Ulcers Clinical Trial
        • Table ReGenerCell - Diabetic Foot Ulcers - A Feasibility Study of the ReGenerCell Autologous Cell Harvesting Device for Diabetic Foot Ulcers
    • ReGenerCell - Venous Leg Ulcers
      • ReGenerCell - Venous Leg Ulcers Product Overview
        • Table ReGenerCell - Venous Leg Ulcers - Product Status
        • Table ReGenerCell - Venous Leg Ulcers - Product Description
    • ReNovaCell - Aesthetics And Repigmentation
      • ReNovaCell - Aesthetics And Repigmentation Product Overview
        • Table ReNovaCell - Aesthetics And Repigmentation - Product Status
        • Table ReNovaCell - Aesthetics And Repigmentation - Product Description
      • ReNovaCell - Aesthetics And Repigmentation Clinical Trial
        • Table ReNovaCell - Aesthetics And Repigmentation - Autologous Cell Suspension Grafting Using ReNovacell in Non-segmental Vitiligo Patients: A Randomized Controlled Study
  • Avita Medical Ltd - Key Competitors
  • Avita Medical Ltd - Key Employees
    • Table Avita Medical Ltd, Key Employees
  • Avita Medical Ltd - Key Employee Biographies
    • Table Avita Medical Ltd, Key Employee Biographies
  • Avita Medical Ltd - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
      • Table Avita Medical Ltd, Other Locations
      • Table Avita Medical Ltd, Subsidiaries
    • Joint Venture
      • Table Avita Medical Ltd, Joint Venture
  • Recent Developments
    • Avita Medical Ltd, Recent Developments
      • Jul 19, 2018: AVITA Medical Announces Expansion of Management Team to Support Planned U.S. Launch of RECELL Device
      • Jun 27, 2018: AVITA Medical Announces Acquisition of Manufacturing Facility to Support Planned U.S. Launch of RECELL Device
      • Jun 26, 2018: AVITA Medical Announces Presentation of RECELL Device Clinical Trial Results at Changhai Academic Week for Burns Treatment Conference in China
      • Jun 25, 2018: AVITA Medical RECELL Device Pivotal Trial Results in Second-Degree Burns Published in Journal of Burn Care & Research
      • Jun 06, 2018: AVITA Medical Announces Institutional Placement of A$16.0 Million to Support U.S. Commercialization of the RECELL Device
      • May 21, 2018: AVITA Medical Announces Presentation at ISPOR Meeting Validating Acute Burn Health Economic Model
      • Apr 12, 2018: RECELL Study in Facial Burns Shows Excellent Cosmetic Outcomes
      • Apr 11, 2018: AVITA Medical Announces RECELLData Demonstrating Statistically Significant Reduction in Donor Skin Requirements and Pain, Increased Patient Satisfaction and Improved Donor Scar Outcomes for Second -Degree Burn Patients
      • Apr 03, 2018: AVITA Medical Announces Schedule for Six RECELL Device Presentations at American Burn Association (ABA) 50th Annual Meeting
      • Mar 26, 2018: AVITA Medical Announces RECELL Health Economic Model to be Presented at ISPOR 23rd Annual International Meeting
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report